Filorga Launches New Anti-Aging Serum and Cream
Skincare brand Filorga has released a new anti-aging duo, TIME-FILLER SHOT 5XP serum and an accompanying cream. The products are inspired by aesthetic medicine and are formulated to target all types of wrinkles.
- The brand is owned by Colgate-Palmolive, which acquired Laboratoires Filorga Cosmétiques for approximately $1.69 billion in 2019. This acquisition was part of Colgate-Palmolive's strategy to expand into the premium skincare market and focus on higher-margin businesses. - Filorga was founded in 1978 by Dr. Michel Tordjman, a French aesthetic doctor, and the brand is positioned within the "medi-cosmetique" category, blending cosmetic and medical science. - The TIME-FILLER SHOT 5XP serum's formula is highly concentrated with 60% active ingredients. It contains a neuropeptide complex, including Acetyl Hexapeptide-8 and Acetyl Octapeptide-3, which is designed to mimic the muscle-relaxing effect of botulinum toxin to smooth expression lines. - Filorga utilizes a multi-channel distribution strategy that includes pharmacies, online sales, specialty stores, and the travel retail channel. The acquisition by Colgate provided an entry for the parent company into the travel retail sector, especially in Asia. - The brand is sold in over 60 countries, with its primary markets being France, Italy, Spain, and Greater China. - While Filorga's traditional customer base in France is women over 40, its target demographic in the growing Chinese market is significantly younger, often under 35.
